#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16576	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2078	791.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1682	1682	T	989	T	873	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16576	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2078	791.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	1050	C	949	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3609	848.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1732	1732	A	1022	A,G	937,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3609	848.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2366	2366	C	970	C,T	866,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3609	848.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2440	2440	A	978	A	886	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30738	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3609	848.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2992	2992	C	959	C,G	872,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2490	folP	855	855	100.0	folP.l15.c4.ctg.1	1514	163.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1002	1004	AGC	238;237;238	A;G;C	213;215;215	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6024	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3403	176.3	1	SNP	p	S91F	1	.	.	271	273	TTC	550	552	TTC	196;196;194	T;T;C	178;177;177	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6024	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3403	176.3	1	SNP	p	G95N	0	.	.	283	285	GGC	562	564	GGC	198;198;195	G;G;C	181;180;177	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6024	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3403	176.3	1	SNP	p	D95G	1	.	.	283	285	GGC	562	564	GGC	198;198;195	G;G;C	181;180;177	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1908	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1336	142.1	1	SNP	p	G45D	0	.	.	133	135	GGC	457	459	GGC	261;261;258	G;G;C	239;236;236	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	932	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1121	82.9	0	.	n	.	0	A197.	DEL	197	197	A	583	583	A	195	A	178	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5680	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2934	192.6	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1497	1499	GTC	210;213;215	G;T;C	193;188;196	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5680	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2934	192.6	1	SNP	p	D86N	0	.	.	256	258	GAC	603	605	GAC	216;216;215	G;A;C,T,A	204;201;201,1,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5680	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2934	192.6	1	SNP	p	S87R	1	.	.	259	261	CGT	606	608	CGT	216;216;216	C;G;T	203;202;202	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5680	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2934	192.6	1	SNP	p	R87W	0	.	.	259	261	CGT	606	608	CGT	216;216;216	C;G;T	203;202;202	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5680	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2934	192.6	1	SNP	p	R87I	0	.	.	259	261	CGT	606	608	CGT	216;216;216	C;G;T	203;202;202	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5680	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2934	192.6	1	SNP	p	S88P	0	.	.	262	264	TCC	609	611	TCC	213;215;214	T;C,A;C	196;198,1;200	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5104	parE	1986	1986	99.95	parE.l6.c4.ctg.1	2615	194.0	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1333	1335	TGC	233;232;228	T;G;C	213;214;213	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5104	parE	1986	1986	99.95	parE.l6.c4.ctg.1	2615	194.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1543	1545	GGC	250;249;250	G;G;C	228;226;226	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1237	1239	GCA	284;287;285	G;C;A	250;256;261	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1240	1242	ATC	285;289;288	A;T;C	259;263;261	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1252	1254	GTG	285;286;285	G,T;T;G	260,1;263;262	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1252	1254	GTG	285;286;285	G,T;T;G	260,1;263;262	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1756	1758	ACC	269;269;271	A;C;C,T	234;239;240,1	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1810	1812	GCG	259;257;254	G;C,G;G	222;200,1;206	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1810	1812	GCG	259;257;254	G;C,G;G	222;200,1;206	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1933	1935	GGC	211;210;212	G;G;C	195;192;190	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1942	1944	GGC	215;217;217	G;G;C	191;193;192	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4918	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2368	206.7	1	SNP	p	P552S	1	.	.	1654	1656	TCG	1960	1962	TCG	215;215;213	T,G;C;G	136,10;158;169	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6730	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3051	219.4	0	.	p	.	0	E418G	NONSYN	1252	1254	GAG	1564	1566	GGG	223;225;224	G;G;G	204;205;204	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6730	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3051	219.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1573	1575	CCG	220;220;218	C;C;G	199;202;197	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2664	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1752	151.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	531	531	C	172	C	159	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1499	217.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	938	938	T	259	T	233	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1499	217.1	1	SNP	p	G120K	0	.	.	358	360	GGT	665	667	GGT	277;278;278	G,A;G,A;T,G	239,1;243,1;240,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1499	217.1	1	SNP	p	A121N	0	.	.	361	363	GCC	668	670	GCC	280;277;272	G;C,A;C	239;240,1;243	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1499	217.1	1	SNP	p	A121D	0	.	.	361	363	GCC	668	670	GCC	280;277;272	G;C,A;C	239;240,1;243	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12512	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4669	266.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1925	1927	AAT	269;269;269	A,C;A;T	241,1;239;238	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1308	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	948	136.0	1	SNP	p	V57M	1	.	.	169	171	ATG	469	471	ATG	287;286;290	A;T;G,T	262;261;265,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
